Clinical Trial: A Phase 1 Study of CAR T Cells in Participants with Relapsing or Progressive Forms of MS
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540, the investigational therapy, in people with relapsing or progressive forms of MS. CAR T cell therapy is specifically manufactured for each individual patient using their o...
Get Details